Enhancement of biophysical activity of lung surfactant extracts and phospholipid-apoprotein mixtures by surfactant protein A

A. R. Venkitaraman, Stephen (Steve) Hall, J. A. Whitsett, R. H. Notter

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

The effects of surfactant protein (SP)-A on the dynamic surface tension lowering and resistance to inhibition of dispersions of calf lung surfactant extract (CLSE) and mixtures of synthetic phospholipids combined with SP-B, C hydrophobic apoproteins were studied at 37°C and rapid cycling rate (20 cyles/min). Addition of SP-A to CLSE, which already contains SP-B and -C, gave a slight improvement in the time course of surface tension lowering on an oscillating bubble apparatus in the absence of inhibitory protein molecules such as albumin or hemoglobin. However, when these proteins were present at concentrations of 10-50 mg/ml, SP-A substantially improved the resistance of CLSE to their inhibitory effects. The beneficial effect of SP-A required the presence of Ca2+ ions, and disappeared when EDTA was substituted for this divalent cation in the subphase. The effect was also retained when SP-A was heated to 50°C prior to addition to CLSE, but was abolished by heating SP-A to 99°C. Additional studies showed that similar improvements in resistance to inhibition were found when SP-A was added to synthetic mixtures of dipalmitoyl phosphatidylcholine (DPPC):egg phosphatidylgylcerol (PG) (80:20 by weight) reconstituted with 1% SP-B or SP-B and -C, but not to phospholipid mixtures containing only SP-C. The requirements for SP-B and calcium for the beneficial effects of SP-A on surface activity suggest that the formation of ordered, larger phospholipid-apoprotein aggregates may be involved in the process. The finding that SP-A enhances the ability of CLSE and other surfactant mixtures containing SP-B to resist inhibition is an advantage that will need to be weighed against other factors such as increased antigenicity and heat sensitivity in the therapeutic applications in surfactant replacement therapy.

Original languageEnglish (US)
Pages (from-to)185-193
Number of pages9
JournalChemistry and Physics of Lipids
Volume56
Issue number2-3
DOIs
StatePublished - 1990
Externally publishedYes

Fingerprint

Pulmonary Surfactant-Associated Protein A
Apoproteins
Surface-Active Agents
Phospholipids
Lung
Protein C
Surface Tension
Surface tension
1,2-Dipalmitoylphosphatidylcholine
Surface resistance
Divalent Cations
Dispersions

Keywords

  • adult respiratory distress syndrome
  • dynamic surface tension lowering
  • pulmonary surfactants
  • surfactant apoproteins
  • surfactant inhibition

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics

Cite this

Enhancement of biophysical activity of lung surfactant extracts and phospholipid-apoprotein mixtures by surfactant protein A. / Venkitaraman, A. R.; Hall, Stephen (Steve); Whitsett, J. A.; Notter, R. H.

In: Chemistry and Physics of Lipids, Vol. 56, No. 2-3, 1990, p. 185-193.

Research output: Contribution to journalArticle

@article{b07d4a99c1e9423a933c49f51c49c90b,
title = "Enhancement of biophysical activity of lung surfactant extracts and phospholipid-apoprotein mixtures by surfactant protein A",
abstract = "The effects of surfactant protein (SP)-A on the dynamic surface tension lowering and resistance to inhibition of dispersions of calf lung surfactant extract (CLSE) and mixtures of synthetic phospholipids combined with SP-B, C hydrophobic apoproteins were studied at 37°C and rapid cycling rate (20 cyles/min). Addition of SP-A to CLSE, which already contains SP-B and -C, gave a slight improvement in the time course of surface tension lowering on an oscillating bubble apparatus in the absence of inhibitory protein molecules such as albumin or hemoglobin. However, when these proteins were present at concentrations of 10-50 mg/ml, SP-A substantially improved the resistance of CLSE to their inhibitory effects. The beneficial effect of SP-A required the presence of Ca2+ ions, and disappeared when EDTA was substituted for this divalent cation in the subphase. The effect was also retained when SP-A was heated to 50°C prior to addition to CLSE, but was abolished by heating SP-A to 99°C. Additional studies showed that similar improvements in resistance to inhibition were found when SP-A was added to synthetic mixtures of dipalmitoyl phosphatidylcholine (DPPC):egg phosphatidylgylcerol (PG) (80:20 by weight) reconstituted with 1{\%} SP-B or SP-B and -C, but not to phospholipid mixtures containing only SP-C. The requirements for SP-B and calcium for the beneficial effects of SP-A on surface activity suggest that the formation of ordered, larger phospholipid-apoprotein aggregates may be involved in the process. The finding that SP-A enhances the ability of CLSE and other surfactant mixtures containing SP-B to resist inhibition is an advantage that will need to be weighed against other factors such as increased antigenicity and heat sensitivity in the therapeutic applications in surfactant replacement therapy.",
keywords = "adult respiratory distress syndrome, dynamic surface tension lowering, pulmonary surfactants, surfactant apoproteins, surfactant inhibition",
author = "Venkitaraman, {A. R.} and Hall, {Stephen (Steve)} and Whitsett, {J. A.} and Notter, {R. H.}",
year = "1990",
doi = "10.1016/0009-3084(90)90101-V",
language = "English (US)",
volume = "56",
pages = "185--193",
journal = "Chemistry and Physics of Lipids",
issn = "0009-3084",
publisher = "Elsevier Ireland Ltd",
number = "2-3",

}

TY - JOUR

T1 - Enhancement of biophysical activity of lung surfactant extracts and phospholipid-apoprotein mixtures by surfactant protein A

AU - Venkitaraman, A. R.

AU - Hall, Stephen (Steve)

AU - Whitsett, J. A.

AU - Notter, R. H.

PY - 1990

Y1 - 1990

N2 - The effects of surfactant protein (SP)-A on the dynamic surface tension lowering and resistance to inhibition of dispersions of calf lung surfactant extract (CLSE) and mixtures of synthetic phospholipids combined with SP-B, C hydrophobic apoproteins were studied at 37°C and rapid cycling rate (20 cyles/min). Addition of SP-A to CLSE, which already contains SP-B and -C, gave a slight improvement in the time course of surface tension lowering on an oscillating bubble apparatus in the absence of inhibitory protein molecules such as albumin or hemoglobin. However, when these proteins were present at concentrations of 10-50 mg/ml, SP-A substantially improved the resistance of CLSE to their inhibitory effects. The beneficial effect of SP-A required the presence of Ca2+ ions, and disappeared when EDTA was substituted for this divalent cation in the subphase. The effect was also retained when SP-A was heated to 50°C prior to addition to CLSE, but was abolished by heating SP-A to 99°C. Additional studies showed that similar improvements in resistance to inhibition were found when SP-A was added to synthetic mixtures of dipalmitoyl phosphatidylcholine (DPPC):egg phosphatidylgylcerol (PG) (80:20 by weight) reconstituted with 1% SP-B or SP-B and -C, but not to phospholipid mixtures containing only SP-C. The requirements for SP-B and calcium for the beneficial effects of SP-A on surface activity suggest that the formation of ordered, larger phospholipid-apoprotein aggregates may be involved in the process. The finding that SP-A enhances the ability of CLSE and other surfactant mixtures containing SP-B to resist inhibition is an advantage that will need to be weighed against other factors such as increased antigenicity and heat sensitivity in the therapeutic applications in surfactant replacement therapy.

AB - The effects of surfactant protein (SP)-A on the dynamic surface tension lowering and resistance to inhibition of dispersions of calf lung surfactant extract (CLSE) and mixtures of synthetic phospholipids combined with SP-B, C hydrophobic apoproteins were studied at 37°C and rapid cycling rate (20 cyles/min). Addition of SP-A to CLSE, which already contains SP-B and -C, gave a slight improvement in the time course of surface tension lowering on an oscillating bubble apparatus in the absence of inhibitory protein molecules such as albumin or hemoglobin. However, when these proteins were present at concentrations of 10-50 mg/ml, SP-A substantially improved the resistance of CLSE to their inhibitory effects. The beneficial effect of SP-A required the presence of Ca2+ ions, and disappeared when EDTA was substituted for this divalent cation in the subphase. The effect was also retained when SP-A was heated to 50°C prior to addition to CLSE, but was abolished by heating SP-A to 99°C. Additional studies showed that similar improvements in resistance to inhibition were found when SP-A was added to synthetic mixtures of dipalmitoyl phosphatidylcholine (DPPC):egg phosphatidylgylcerol (PG) (80:20 by weight) reconstituted with 1% SP-B or SP-B and -C, but not to phospholipid mixtures containing only SP-C. The requirements for SP-B and calcium for the beneficial effects of SP-A on surface activity suggest that the formation of ordered, larger phospholipid-apoprotein aggregates may be involved in the process. The finding that SP-A enhances the ability of CLSE and other surfactant mixtures containing SP-B to resist inhibition is an advantage that will need to be weighed against other factors such as increased antigenicity and heat sensitivity in the therapeutic applications in surfactant replacement therapy.

KW - adult respiratory distress syndrome

KW - dynamic surface tension lowering

KW - pulmonary surfactants

KW - surfactant apoproteins

KW - surfactant inhibition

UR - http://www.scopus.com/inward/record.url?scp=0025649187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025649187&partnerID=8YFLogxK

U2 - 10.1016/0009-3084(90)90101-V

DO - 10.1016/0009-3084(90)90101-V

M3 - Article

VL - 56

SP - 185

EP - 193

JO - Chemistry and Physics of Lipids

JF - Chemistry and Physics of Lipids

SN - 0009-3084

IS - 2-3

ER -